Atyr Pharma (471A.F) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.21
-0.19
-0.17
-0.15

Details

Expected EPS
-0.15802957439999998
Actual EPS
-0.18839039999999999
Surprise EPS
-0.03
Surprise Percent
+19.21%

Description

Atyr Pharma (471A.F) has reported earnings of -0.18839039999999999 per share for Q3 2025.

0 Comments

Share your thoughts